These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

185 related items for PubMed ID: 28689036

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Edetate Disodium-Based Chelation for Patients With a Previous Myocardial Infarction and Diabetes: TACT2 Randomized Clinical Trial.
    Lamas GA, Anstrom KJ, Navas-Acien A, Boineau R, Nemeth H, Huang Z, Wen J, Rosenberg Y, Stylianou M, Jones TLZ, Joubert BR, Yu Q, Santella RM, Mon AC, Ujueta F, Escolar E, Nathan DM, Fonseca VA, Aude YW, Ehrman JK, Elliott T, Prashad R, Lewis EF, Lopes RD, Farkouh ME, Elliott AM, Newman JD, Mark DB, TACT2 Investigators.
    JAMA; 2024 Sep 10; 332(10):794-803. PubMed ID: 39141382
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. The effect of EDTA-based chelation on patients with diabetes and peripheral artery disease in the Trial to Assess Chelation Therapy (TACT).
    Ujueta F, Arenas IA, Escolar E, Diaz D, Boineau R, Mark DB, Golden P, Lindblad L, Kim H, Lee KL, Lamas GA.
    J Diabetes Complications; 2019 Jul 10; 33(7):490-494. PubMed ID: 31101487
    [Abstract] [Full Text] [Related]

  • 7. Baseline characteristics including blood and urine metal levels in the Trial to Assess Chelation Therapy 2 (TACT2).
    Navas-Acien A, Santella RM, Joubert BR, Huang Z, Lokhnygina Y, Ujueta F, Gurvich I, LoIacono NJ, Ravalli F, Ward CD, Jarrett JM, Salazar AL, Boineau R, Jones TLZ, Mark DB, Newman JD, Nathan DM, Anstrom KJ, Lamas GA.
    Am Heart J; 2024 Jul 10; 273():72-82. PubMed ID: 38621575
    [Abstract] [Full Text] [Related]

  • 8. Potential Role of Metal Chelation to Prevent the Cardiovascular Complications of Diabetes.
    Calderon Moreno R, Navas-Acien A, Escolar E, Nathan DM, Newman J, Schmedtje JF, Diaz D, Lamas GA, Fonseca V.
    J Clin Endocrinol Metab; 2019 Jul 01; 104(7):2931-2941. PubMed ID: 30869793
    [Abstract] [Full Text] [Related]

  • 9. Differential Outcomes With Edetate Disodium-Based Treatment Among Stable Post Anterior vs. Non-Anterior Myocardial Infarction Patients.
    Lewis EF, Ujueta F, Lamas GA, Roberts RS, Mark DB, Nahin RL, Goertz C, Stylianou M, Lee KL.
    Cardiovasc Revasc Med; 2020 Nov 01; 21(11):1389-1395. PubMed ID: 32303436
    [Abstract] [Full Text] [Related]

  • 10. Limb Preservation Using Edetate Disodium-based Chelation in Patients with Diabetes and Critical Limb Ischemia: An Open-label Pilot Study.
    Arenas I, Ujueta F, Diaz D, Yates T, Olivieri B, Beasley R, Lamas G.
    Cureus; 2019 Dec 27; 11(12):e6477. PubMed ID: 32025401
    [Abstract] [Full Text] [Related]

  • 11. Heavy Metals, Cardiovascular Disease, and the Unexpected Benefits of Chelation Therapy.
    Lamas GA, Navas-Acien A, Mark DB, Lee KL.
    J Am Coll Cardiol; 2016 May 24; 67(20):2411-2418. PubMed ID: 27199065
    [Abstract] [Full Text] [Related]

  • 12. The trial to assess chelation therapy 2 (TACT2): Rationale and design.
    Lamas GA, Anstrom KJ, Navas-Acien A, Boineau R, Kim H, Rosenberg Y, Stylianou M, Jones TLZ, Joubert BR, Santella RM, Escolar E, Aude YW, Fonseca V, Elliott T, Lewis EF, Farkouh ME, Nathan DM, Mon AC, Gosnell L, Newman JD, Mark DB, TACT2 Investigators.
    Am Heart J; 2022 Oct 24; 252():1-11. PubMed ID: 35598636
    [Abstract] [Full Text] [Related]

  • 13. Chronic Toxic Metal Exposure and Cardiovascular Disease: Mechanisms of Risk and Emerging Role of Chelation Therapy.
    Aneni EC, Escolar E, Lamas GA.
    Curr Atheroscler Rep; 2016 Dec 24; 18(12):81. PubMed ID: 27822681
    [Abstract] [Full Text] [Related]

  • 14. EDTA chelation effects on urinary losses of cadmium, calcium, chromium, cobalt, copper, lead, magnesium, and zinc.
    Waters RS, Bryden NA, Patterson KY, Veillon C, Anderson RA.
    Biol Trace Elem Res; 2001 Dec 24; 83(3):207-21. PubMed ID: 11794513
    [Abstract] [Full Text] [Related]

  • 15. Chelation therapy to prevent diabetes-associated cardiovascular events.
    Diaz D, Fonseca V, Aude YW, Lamas GA.
    Curr Opin Endocrinol Diabetes Obes; 2018 Aug 24; 25(4):258-266. PubMed ID: 29846236
    [Abstract] [Full Text] [Related]

  • 16. Trace element homeostasis during continuous sedation with propofol containing EDTA versus other sedatives in critically ill patients.
    Higgins TL, Murray M, Kett DH, Fulda G, Kramer KM, Gelmont D, Dedhia HV, Levy H, Teres D, Zaloga GP, Ko H, Thompson KA.
    Intensive Care Med; 2000 Aug 24; 26 Suppl 4():S413-21. PubMed ID: 11310904
    [Abstract] [Full Text] [Related]

  • 17. Urinary excretion of essential metals following intravenous calcium disodium edetate: an estimate of free zinc and zinc status in man.
    Powell JJ, Burden TJ, Greenfield SM, Taylor PD, Thompson RP.
    J Inorg Biochem; 1999 Jun 30; 75(3):159-65. PubMed ID: 10474201
    [Abstract] [Full Text] [Related]

  • 18. A comparison of sodium calcium edetate (edetate calcium disodium) and succimer (DMSA) in the treatment of inorganic lead poisoning.
    Bradberry S, Vale A.
    Clin Toxicol (Phila); 2009 Nov 30; 47(9):841-58. PubMed ID: 19852620
    [Abstract] [Full Text] [Related]

  • 19. EDTA Chelation Therapy to Reduce Cardiovascular Events in Persons with Diabetes.
    Ouyang P, Gottlieb SH, Culotta VL, Navas-Acien A.
    Curr Cardiol Rep; 2015 Nov 30; 17(11):96. PubMed ID: 26364188
    [Abstract] [Full Text] [Related]

  • 20. Metal chelation therapy in rheumathoid arthritis: a case report. Successful management of rheumathoid arthritis by metal chelation therapy.
    Bamonti F, Fulgenzi A, Novembrino C, Ferrero ME.
    Biometals; 2011 Dec 30; 24(6):1093-8. PubMed ID: 21655943
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.